THURSDAY, Jan. 27, 2022 (HealthDay News) — Taking vitamin D supplements may help stave off psoriasis, rheumatoid arthritis, lupus and other autoimmune diseases, a new study suggests. Previous research has hinted at this connection, but the new study is the first randomized controlled trial to look at what happens when people are given vitamin D… read on > read on >
Finding the right medication for rheumatoid arthritis isn’t easy, and a newer pill against the disease carries higher risks of heart attack, stroke and cancer than older RA drugs, a new clinical trial confirms. The study was mandated by the U.S. Food and Drug Administration after earlier safety signals about the drug, called tofacitinib (Xeljanz).… read on > read on >
Allopurinol, a frequently used gout medication, does not appear to drive up the risk for dying among gout patients who also struggle with chronic kidney disease, new research shows. The finding is based on an analysis of two decades worth of British health records. And it may put to rest recent concerns regarding a well-known… read on > read on >
Belly fat is usually unwelcome, but new research suggests it may actually be good for something: relief from foot pain. A small pilot study suggests that an injection of a patient’s own fat cells can help ease the often-excruciating heel pain brought on by a condition known as plantar fasciitis. “We take a small amount… read on > read on >
TUESDAY, Jan. 25, 2022 (HealthDay News) – Older adults who maintain a steady weight as they age are less likely to experience rapid cognitive decline, regardless of how much they weigh to start, new research suggests. “There’s something about maintaining weight and BMI that seems to reflect some health resilience,” said study author Michal Schnaider… read on > read on >
MONDAY, Jan. 24, 2022 (healthDay News) — The U.S. Food and Drug Administration said Monday that it will curtail the use of two monoclonal antibody treatments that do not appear to work against the highly contagious Omicron variant. The combo treatments bamlanivimab/etesevimab and casirivimab/imdevimab, made by Eli Lilly and Regeneron, respectively, performed well against earlier… read on > read on >
MONDAY, Jan. 24, 2022 (HealthDay Now) — Alaina Stanisci has grappled with an eating disorder since she was 10, and the disruptions of the pandemic only made things worse for the high school senior. “I actually experienced a relapse at the beginning of the pandemic because of this lack of structure,” Stanisci, 18, of Mountain… read on > read on >
MONDAY, Jan. 24, 2022 (healthDay News) — The U.S. Food and Drug Administration may soon curtail the use of two monoclonal antibody treatments that do not appear to work against the highly contagious Omicron variant. The treatments made by Regeneron and Eli Lilly performed well against earlier variants, but only GlaxoSmithKline’s antibody therapy has stayed… read on > read on >
Losing weight before beginning fertility treatment doesn’t boost the odds that a woman who is obese will have a successful pregnancy, a new study shows. Obesity has been linked with difficulty conceiving, as well as pregnancy complications and loss. Many women who are obese and want to get pregnant are advised to lose weight to… read on > read on >
Some kids might be able to get over their peanut allergy if they start immunotherapy while they’re still toddlers, a major new clinical trial reports. In the trial, a group of 1- to 3-year-olds with severe peanut allergies were safely fed gradually increasing daily doses of a peanut protein flour to help accustom their immune… read on > read on >
